Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of IN-M00007 and IN-R00007 in healthy volunteers
NCT07311811Phase 1Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan (2 arms), sponsored by HK inno.N Corporation. Primary endpoints: Area Under the Curve at 48 hours, Maximum Plasma Concentration at 48 hours and 2 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tegoprazan
Beyond the preview
Go deeper on NCT07311811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311811.